Cabot (NYSE:CBT) Releases Earnings Results, Beats Estimates By $0.14 EPS

Cabot (NYSE:CBT) released its quarterly earnings results on Tuesday. The specialty chemicals company reported $1.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.47 by $0.14, Zacks reports. Cabot had a net margin of 8.62% and a return on equity of 22.82%. The business had revenue of $904.00 million for the quarter, compared to analyst estimates of $900.31 million. During the same quarter in the previous year, the business earned $1.90 earnings per share. The firm’s revenue was down 3.4% compared to the same quarter last year. Cabot updated its FY 2026 guidance to 6.000-6.50 EPS.

Cabot Price Performance

NYSE:CBT opened at $83.43 on Wednesday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.09 and a current ratio of 1.67. The company has a 50-day moving average of $73.67 and a 200-day moving average of $70.26. Cabot has a 52 week low of $58.33 and a 52 week high of $84.37. The company has a market capitalization of $4.36 billion, a price-to-earnings ratio of 14.61, a PEG ratio of 10.00 and a beta of 0.78.

Cabot Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 12th. Stockholders of record on Friday, May 29th will be issued a dividend of $0.4725 per share. This represents a $1.89 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date of this dividend is Friday, May 29th. This is a positive change from Cabot’s previous quarterly dividend of $0.45. Cabot’s payout ratio is 31.52%.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. AQR Capital Management LLC boosted its holdings in Cabot by 123.0% during the second quarter. AQR Capital Management LLC now owns 867,946 shares of the specialty chemicals company’s stock valued at $65,096,000 after purchasing an additional 478,702 shares in the last quarter. UBS Group AG lifted its position in shares of Cabot by 186.7% during the 3rd quarter. UBS Group AG now owns 593,510 shares of the specialty chemicals company’s stock worth $45,136,000 after buying an additional 386,514 shares during the period. Healthcare of Ontario Pension Plan Trust Fund acquired a new stake in Cabot in the 4th quarter valued at $8,785,000. Fuller & Thaler Asset Management Inc. grew its position in Cabot by 5.6% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 2,343,322 shares of the specialty chemicals company’s stock valued at $155,315,000 after acquiring an additional 124,613 shares during the period. Finally, Goldman Sachs Group Inc. lifted its holdings in shares of Cabot by 32.5% during the first quarter. Goldman Sachs Group Inc. now owns 442,646 shares of the specialty chemicals company’s stock valued at $36,802,000 after acquiring an additional 108,645 shares during the period. Institutional investors own 93.18% of the company’s stock.

Key Cabot News

Here are the key news stories impacting Cabot this week:

• Positive Sentiment: Quarterly results beat expectations — adjusted EPS of $1.61 topped the consensus $1.47 and revenue of $904M was roughly in line, showing the company outperformed street estimates this quarter. Cabot (CBT) Surpasses Q2 Earnings Estimates
• Positive Sentiment: Battery materials and segment performance showing strength — management cited battery materials momentum and meaningful EBITDA contribution; Reinforcement Materials EBIT was $93M and Performance Chemicals EBIT $59M, supporting growth narrative. Cabot Corporation Reports Second Quarter Fiscal Year 2026 Results
• Positive Sentiment: Board raised the quarterly dividend by 5% (new quarterly $0.4725; annualized $1.89), boosting yield and returning cash to shareholders. Cabot Corporation Board Increases Dividend
• Neutral Sentiment: FY?2026 EPS guidance set to $6.00–$6.50 (street consensus ~6.24) — range essentially encompasses the consensus, so guidance is not a clear positive or negative surprise for investors.
• Neutral Sentiment: Company hosted an earnings call and posted slides/transcript for investors to assess details and modeling assumptions. Listen to Conference Call
• Negative Sentiment: Revenue and EPS are down year?over?year (revenue down ~3.4%; GAAP EPS declined vs prior year), highlighting near?term demand softness in parts of the business. Cabot Corporation Reports Second Quarter Fiscal Year 2026 Results
• Negative Sentiment: Company announced plans to pursue asset optimization, including potential closures of manufacturing operations in South America and Europe — possible near?term restructuring costs and local consultation risks. Cabot Corporation Reports Second Quarter Fiscal Year 2026 Results

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on CBT shares. Zacks Research raised shares of Cabot from a “strong sell” rating to a “hold” rating in a research note on Tuesday, January 27th. Mizuho lifted their price objective on Cabot from $75.00 to $80.00 and gave the company a “neutral” rating in a research report on Wednesday. UBS Group raised their price target on Cabot from $74.00 to $81.00 and gave the stock a “neutral” rating in a research note on Thursday, February 5th. Finally, Jefferies Financial Group reissued a “buy” rating and issued a $85.00 target price on shares of Cabot in a research report on Wednesday, February 4th. One equities research analyst has rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $75.00.

About Cabot

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.